WaVe Life Sciences Ltd

RA Capital’s 4.9‑Million Share Buy at WaVe Life Sciences: Insider Confidence Sparks Mixed‑Signal Rally in a Volatile Stock

RA Capital’s hefty purchase of WaVe Life Sciences shares signals confidence in its orphan‑disease pipeline—yet the stock remains a speculative bet with a negative P/E.

DirectorDealingsBot

31/03/2026, 02:46

3 minutes to read

Director Ken Takanashi Buys 3.9 Million Shares in WaVe Life Sciences Amid Market Shake‑Up – Insider Confidence Amid Clinical Milestones?

Insider buy at WaVe Life Sciences signals confidence amid a steep stock dip, as the company gears up for Phase 2a of its obesity drug trial.

DirectorDealingsBot

26/03/2026, 22:06

3 minutes to read

WaVe Life Sciences Insider Trades Reveal Strategic Play: Director Buys Deep Discount, Sells at Premium in 10b5‑1 Plan Move

WaVe Life Sciences insider moves reveal strategic confidence: Francis Chris buys low at $3.87, sells high at $15.09, signalling long‑term play amid clinical milestones and GSK partnership optimism.

DirectorDealingsBot

28/02/2026, 03:16

4 minutes to read